株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオセンサーの世界市場分析・予測 2020年:電気化学バイオセンサー・圧電バイオセンサー・光バイオセンサー

Biosensors Market by Application (POC, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring), Product (Wearable, Non-Wearable), Technology (Electrochemical, Piezoelectric, Optical) & Geography - Global Analysis & Forecast to 2020

発行 MarketsandMarkets 商品コード 324151
出版日 ページ情報 英文 193 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
バイオセンサーの世界市場分析・予測 2020年:電気化学バイオセンサー・圧電バイオセンサー・光バイオセンサー Biosensors Market by Application (POC, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring), Product (Wearable, Non-Wearable), Technology (Electrochemical, Piezoelectric, Optical) & Geography - Global Analysis & Forecast to 2020
出版日: 2015年01月14日 ページ情報: 英文 193 Pages
概要

世界のバイオセンサー市場規模は2013年に113億9,000万米ドルとなり、2014年から2020年間は10.00%のCAGRで推移し、2020までに226億8,000万米ドルに達すると予測されています。

当レポートでは、世界のバイオセンサー市場について調査分析し、製品、技術、用途、および地域別の市場分析と予測を提供するほか、競合状況および主要企業のプロファイルをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 様々な臨床・非臨床用途におけるバイオセンサーの導入がバイオセンサー市場を促進
  • 全体的なバイオセンサー市場でポイントオブケア(POC)が大半を占める
  • アジア太平洋地域におけるバイオセンサー市場の成長を支える主な要因:従来型医療制度のアップグレードおよび人口の多さ
  • 技術進歩および医療費の上昇は米国におけるバイオセンサー市場を促進する見込み
  • 北米は引き続きバイオセンサー用途向け市場で優位に立つ見込み
  • バイオセンサー市場:先進国vs.新興国
  • ウェアラブルバイオセンサーは世界の医療産業に影響を及ぼす可能性

第5章 市場概要

  • イントロダクション
  • バイオセンサー技術の進化
  • 市場区分
    • 用途別
    • 技術別
    • 製品別
    • 地域別
  • 市場力学
    • 推進因子
      • ナノテクノロジー/ナノバイオセンサーの登場
      • ここ数年間の大きな技術進歩
      • 糖尿病患者における血糖値モニタリング
      • 家庭用POC装置の需要の増加
    • 抑制要因
      • 商業化の遅れ
      • 研究・開発関連コストの高さ
      • 新しい治療行為の導入へのためらい
    • 市場機会
      • 新興諸国における新しい機会
      • 食品産業、環境モニタリング、およびバイオディフェンスといった非医療用途向けバイオセンサーの利用
    • 課題
      • 政府規制:長い認定&認可サイクル
      • ポイントオブケア(POC)市場における価格圧力
    • 緊急の課題
      • 装置の高コストがバイオセンサー市場の成長を抑制

第6章 産業動向

  • イントロダクション
  • バリューチェーン分析
    • バリューチェーン分析:バイオセンサー
  • 産業動向
  • 新興動向
    • オープンソース・コネクテッド医療プラットフォーム
    • 個別化医療:医療モデル
    • ラボ・オン・チップ
  • バイオセンサープラットフォームおよびビジネスモデル
  • ポーターのファイブフォース分析
  • PEST分析
    • 政治的要因
    • 経済的要因
    • 社会的要因
    • 技術的要因
  • 戦略的ベンチマーキング
    • 技術統合 & 製品強化
    • 腫瘍/癌検査市場への参入

第7章 バイオセンサー市場分析:用途別

  • イントロダクション
  • ポイント・オブ・ケア(POC)
    • ポイント・オブ・ケア(POC)用途:地域別
    • ポイント・オブ・ケア(POC)用途:製品別
    • 血糖値モニタリング
    • 心筋マーカー
    • 感染症検査キット
    • 凝固モニタリングキット
    • 妊娠および受胎検査キット
    • 血液ガス・電解質検査
    • 腫瘍/癌マーカー
    • 尿検査試験キット
    • コレステロール試験
    • その他
  • 在宅診断
    • 在宅診断用途:地域別
    • 在宅診断用途:製品別
  • リサーチラボ
  • 生物防衛
  • 環境モニタリング
    • 食品産業

第8章 バイオセンサー市場分析:技術別

  • イントロダクション
    • バイオセンシング技術(バイオトランデューザ)の比較分析
  • 電気化学バイオセンサー
    • 電気化学バイオセンサーのメリット
    • 主要企業
    • 電気伝導バイオセンサー
    • 電流測定バイオセンサー
    • 電位差バイオセンサー
    • その他
  • 圧電バイオセンサー
  • 光バイオセンサ
  • 熱バイオセンサー
  • その他

第9章 バイオセンサー市場分析:製品別

  • イントロダクション
  • ウェアラブルバイオセンサー
    • リストウェア
    • アイウェア
    • フットウェア
    • ネックウェア
    • ボディウエア
    • その他
  • 非ウェアラブルバイオセンサー

第10章 バイオセンサー市場分析:地域別

  • イントロダクション
  • 北米
  • 欧州
  • APAC(アジア太平洋地域)
  • その他の地域(ROW)

第11章 競合情勢

  • 概要
  • 市場シェア分析:バイオセンサー市場
  • 競合状況・動向

第12章 企業プロファイル(概要・製品およびサービス・財務・戦略&発展)

  • Abbott point of care, inc.
  • Acon laboratories, Inc.
  • Bayer ag
  • F. hoffman la-roche ltd.
  • LifeScan Inc.
  • LifeSensors Inc.
  • Medtronic inc.
  • Nova biomedical corporation
  • Pharmaco-kinesis corporation
  • Siemens AG
  • Universal Biosensors

第13章 付録

図表一覧

目次
Product Code: SE 3097

The biosensor is a device which is used for detecting, recording, and transmitting information related to any physiological changes or the presence of various chemicals or biological materials in the environment. In other words, we can say that it is an analytical device, which converts the biological response into electrical signals. The biosensors technology is now being used for the development of various biosensor applications, such as the medical, healthcare, biodefense, environment monitoring, and food industries.

This report is based on an extensive research study of the biosensors market and aims at identifying the entire market and all its sub-segments through the extensively detailed classifications. The demand for the biosensors is expecting a significant growth and importance among the industry players across various verticals. APAC is projected to be the fastest growing markets due to the high adoption of medical diagnostics and testing devices.

This report is focused on giving a bird's eye-view of the industry with regard to the biosensors market, with qualitative analysis at each and every aspect of the classification done on the basis of products, technologies, applications, and geographies. The report provides a forecast of the growth of the biosensors market from 2014 to 2020. A complete competitive landscape of the current market is analyzed from the market share analysis and rankings of current key players; all the other details of the key players are discussed in their company profiles. The competitive information provided in this report includes market shares of the leading companies in the biosensors ecosystem, key developments, core strategies deployed by various players, mergers and acquisitions, new product developments, collaborations, and joint ventures of key manufacturers along with their company profiles.

The report also discusses the future of the global market with road-maps, upcoming technologies, markets, and applications with respect to the biosensors market. The key players in this industry include F. Hoffmann-La Roche Ltd. (Switzerland), LifeScan Inc. (U.S.), Bayer Healthcare AG (Germany), Abbott Point-of-Care Inc. (U.S.), Medtronic (U.S.), Siemens Healthcare (Germany), and others.

Table of Contents

1 introduction

  • 1.1 objectives of the study
  • 1.2 market definition
  • 1.3 study scope
    • 1.3.1 markets covered
    • 1.3.2 geographic scope
    • 1.3.3 Years considered for the study
  • 1.4 currency
  • 1.5 package size
  • 1.6 limitations
  • 1.7 stakeholders

2 research methodology

  • 2.1 research data
    • 2.1.1 secondary data
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 primary data
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primaries
  • 2.2 factor analysis
    • 2.2.1 introduction
    • 2.2.2 demand side analysis
      • 2.2.2.1 Growth in the Healthcare Expenditure
      • 2.2.2.2 Progression Toward Healthcare Decentralization
      • 2.2.2.3 Prevalence of Diabetes Continues to Increase
      • 2.2.2.4 Rapid Growth of the Aging Population
      • 2.2.2.5 Related Market Analysis: Transducers Market
      • 2.2.2.6 Poor Customer Perception
  • 2.3 Market size estimation
    • 2.3.1 Bottom-up approach
    • 2.3.2 top-down approach
  • 2.4 MARKET breakdown & DATA TRIANGULATION
  • 2.5 research assumptions and limitations
    • 2.5.1 assumptions
    • 2.5.2 limitations

3 Executive Summary

4 Premium insights

  • 4.1 adoption of biosensors in various CLINICAL and non-CLINICAL applications is driving THE biosensors Market
  • 4.1 point-of-care dominated the overall biosensors market, 2013
  • 4.2 key factors behind the growth of the biosensors market in APAC- upgrade of the existing healthcare systems & large population
  • 4.3 technological advancements & increased healthcare cost likely to drive the biosensors market in the U.S.
  • 4.4 north america expected to continue to dominate the market for biosensor applications
  • 4.5 Biosensors market: Developed vs. developing nations
  • 4.6 wearable biosensors likely to impact the global healthcare industry

5 Market Overview 4

  • 5.1 Introduction
  • 5.2 Evolution of the biosensors technology
  • 5.3 Market segmentation
    • 5.3.1 biosensors market, by application
    • 5.3.2 Biosensors market, by technology
    • 5.3.3 biosensors market segmentation: by product
    • 5.3.4 BIOSENSORS market segmentation: by geography
  • 5.4 Market dynamics
    • 5.4.1 Drivers
      • 5.4.1.1 Emergence of Nanotechnology/Nanobiosensors
      • 5.4.1.2 Significant technological advancements over the last few years
      • 5.4.1.3 Glucose monitoring in diabetics patients
      • 5.4.1.4 Increase in the demand for home based POC devices
    • 5.4.2 Restraints
      • 5.4.2.1 Slow rate of commercialization
      • 5.4.2.2 High cost involved in the research and development
      • 5.4.2.3 Reluctance toward the adoption of new treatment practices
    • 5.4.3 opportunities
      • 5.4.3.1 Emerging market in the developing countries
      • 5.4.3.2 Use of biosensors for non-medical applications, such as- the food industry, environmental monitoring, and biodefense
    • 5.4.4 Challenges
      • 5.4.4.1 Government regulations-long certification & approval cycles
      • 5.4.4.2 Pricing pressure in the point-of-care market
    • 5.4.5 burning issue
      • 5.4.5.1 High cost devices limit the growth of the biosensors market

6 industry trends 5

  • 6.1 introduction
  • 6.2 VALUE CHAIN ANALYSIS
    • 6.2.1 Value chain analysis: Biosensors
  • 6.3 industry trends
  • 6.4 emerging trends
    • 6.4.1 open, connected healthcare platforms
    • 6.4.2 personalized medicine -A medical model
    • 6.4.3 lAB ON A CHIP
  • 6.5 biosensors platform and business model
  • 6.6 PORTER'S FIVE FORCES ANALYSIS
    • 6.6.1 threats of new entrants
    • 6.6.2 threats of substitutes
    • 6.6.3 bargaining power of suppliers
    • 6.6.4 bargaining power of buyers
    • 6.6.5 Intensity of rivalry
  • 6.7 pEST ANALYSIS
    • 6.7.1 political factors
    • 6.7.2 economic factors
    • 6.7.3 social factors
    • 6.7.4 technological factors
  • 6.8 strategic benchmarking
    • 6.8.1 TECHNOLOGY INTEGRATION & PRODUCT ENHANCEMENT
    • 6.8.2 ENTRY INTO TUMOR/CANCER TESTING MARKET

7 biosensors market analysis, by application 7

  • 7.1 introduction
  • 7.2 point-of-care
    • 7.2.1 Point-of-Care Application, by Geography
    • 7.2.2 Point-of-Care Application, by Product
    • 7.2.3 glucose monitoring
    • 7.2.4 cardiac markers
    • 7.2.5 infectious diseases testing kits
    • 7.2.6 coagulation monitoring kits
    • 7.2.7 pregnancy and fertility testing kits
    • 7.2.8 blood gas and electrolyte
    • 7.2.9 tumor/cancer markers
    • 7.2.10 urinalysis testing kits
    • 7.2.11 cholesterol test
    • 7.2.12 others
  • 7.3 home diagnostics
    • 7.3.1 Home Diagnostics Application, by Geography
    • 7.3.2 Home Diagnostics Application, by Product
  • 7.4 research labs
    • 7.4.1 Research Lab Application, by Geography
    • 7.4.2 Research Lab Application, by Product
  • 7.5 biodefense
    • 7.5.1 Biodefense Application, by Geography
    • 7.5.2 Biodefense Application, by Product
  • 7.6 environmental monitoring
    • 7.6.1 Environmental Monitoring Application, by Geography
    • 7.6.2 Environmental Monitoring, by Product
    • 7.7 food industry

8 Biosensors Market analysis, By Technology 1

  • 8.1 Introduction
    • 8.1.1 Comparative Analysis of biosensing Technologies (biotransducers)
  • 8.2 Electrochemical Biosensors
    • 8.2.1 Advantages of Electrochemical Biosensors
    • 8.2.2 Major Companies
    • 8.2.3 Conductometric biosensors
    • 8.2.4 Amperometric biosensors
    • 8.2.5 potentiometric biosensors
    • 8.2.6 others
  • 8.3 Piezoelectric Biosensors
  • 8.4 Optical biosensors
  • 8.5 thermal biosensors
  • 8.6 Others

9 Biosensors market analysis, by product 1

  • 9.1 introduction
  • 9.2 wearable biosensors
    • 9.2.1 wrist-wear
    • 9.2.2 eye-wear
    • 9.2.3 foot-wear
    • 9.2.4 neck-wear
    • 9.2.5 body-wear
    • 9.2.6 others
  • 9.3 non-wearable biosensors

10 biosensors market analysis, by geography

  • 10.1 INTRODUCTION
  • 10.2 North AMERICA
  • 10.3 Europe
  • 10.4 APAC
  • 10.5 ROW

11 competitive landscape

  • 11.1 Overview
  • 11.2 market share analysis, biosensors market
  • 11.3 competitive situation and trends
    • 11.3.1 new product launches, 2011-2014
    • 11.3.2 Acquisition
    • 11.3.3 partnerships and agreements
    • 11.3.4 Expansions
    • 11.3.5 awards and recognition

12 company profiles (Overview, Products and Services, Financials, Strategy & Development)*

  • 12.1 abbott point of care, inc.
  • 12.2 acon laboratories, Inc.
  • 12.3 bayer ag
  • 12.4 f. hoffman la-roche ltd.
  • 12.5 LifeScan, Inc.
  • 12.6 LifeSensors Inc.
  • 12.7 medtronic inc.
  • 12.8 nova biomedical corporation
  • 12.9 pharmaco-kinesis corporation
  • 12.10 Siemens AG
  • 12.11 Universal Biosensors

*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case Unlisted Companies.

13 Appendix

  • 13.1 insights of industry experts
  • 13.2 discussion guide
  • 13.3 introducing RT: real-time market INTELLIGENce
  • 13.4 available customizations
  • 13.5 Related Reports

LIST OF TABLES

  • TABLE 1 Increase in the demand for glucose monitoring systems, contributing to the growth of the biosensors market
  • TABLE 2 the slow rate of commercialization is hampering the growth of the biosensors market
  • TABLE 3 use of biosensors for non-medical applications is a prominent opportunity for the biosensors market
  • TABLE 4 Stringent government regulations and pricing pressures are the major challenges faced by the biosensors market
  • TABLE 5 Global Biosensor Market Size, by Application, 2013-2020 ($Billion)
  • TABLE 6 Biosensors Market Size, by Point-of-Care Application, 2013-2020 ($Billion)
  • TABLE 7 POC Applications IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 8 poc Applications in the north american BIOSENSORS market, By Country, 2013-2020 ($million)
  • TABLE 9 poc Applications in the EUROPEAN BIOSENSORS market, By Country, 2013-2020 ($Million)
  • TABLE 10 poc Applications in the APAC BIOSENSORS market, By Country, 2013-2020 ($Million)
  • TABLE 11 poc Applications in the BIOSENSORS market, by Product, 2013-2020 ($million)
  • TABLE 12 poc Applications in the BIOSENSORS market, by Product, 2013-2020 ($Million)
  • TABLE 13 Glucose Monitoring kits IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 14 Cardiac Markers IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($Million)
  • TABLE 15 Infectious Diseases testing kits IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 16 Coagulation Monitoring IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 17 Pregnancy & Fertility Testing kits IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 18 Blood Gas & Electrolytes IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 19 Tumor or Cancer Markers in the BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 20 Urinalysis Testing IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($Billion)
  • TABLE 21 CHOLESTEROL Testing IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 22 other applications IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 23 Home Diagnostics IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 24 home diagnostics IN THE NORTH AMERICAN BIOSENSORS MARKET, By Country, 2013-2020 ($million)
  • TABLE 25 home diagnostics IN THE EUROPEAN BIOSENSORS MARKET, By Country, 2013-2020 ($Million)
  • TABLE 26 home diagnostics IN THE APAC BIOSENSORS MARKET, By Country, 2013-2020 ($million)
  • TABLE 27 home diagnostics IN THE BIOSENSORS MARKET, by Product, 2013-2020 ($Million)
  • TABLE 28 home diagnostics IN THE WEARABLE BIOSENSORS MARKET, by product, 2013-2020 ($million)
  • TABLE 29 Research Labs IN THE BIOSENSORS MARKET, By Region, 2013-2020 ($million)
  • TABLE 30 Research Labs IN THE NORTH AMERICAN BIOSENSORS MARKET, By Country, 2013-2020 ($million)
  • TABLE 31 Research Labs IN THE European Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 32 Research Labs IN THE APAC Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 33 Research lab IN THE Biosensors Market, by Product, 2013-2020 ($million)
  • TABLE 34 research lab IN THE wearable Biosensors Market, by Product, 2013-2020 ($million)
  • TABLE 35 Biodefense IN THE Biosensors Market, By Region, 2013-2020 ($million)
  • TABLE 36 Biodefense IN THE north american Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 37 Biodefense IN THE European Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 38 Biodefense IN THE APAC Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 39 biodefense applications IN THE Biosensors Market, by Product, 2013-2020 ($Million)
  • TABLE 40 biodefense applications IN THE wearable biosensors market, By product, 2013-2020 ($million)
  • TABLE 41 Environmental Monitoring IN THE biosensors market, By Region, 2013-2020 ($million)
  • TABLE 42 Environmental Monitoring IN THE North American Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 43 Environmental Monitoring IN THE European Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 44 Environmental Monitoring IN THE APAC Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 45 environmental monitoring applications IN THE Biosensors Market, by Product, 2013-2020 ($million)
  • TABLE 46 environmental monitoring applications IN THE WEARABLE Biosensors Market, by product, 2013-2020 ($million)
  • TABLE 47 enzyme biosensor for detecting food components
  • TABLE 48 Food Industry IN THE Biosensors Market, By Region, 2013-2020 ($million)
  • TABLE 49 Food Industry IN THE NORTH AMERICAN Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 50 Food Industry IN THE European Biosensors Market, By Country, 2013-2020 ($Billion)
  • TABLE 51 Food Industry IN THE APAC BIOSENSORS MARKET, By Country, 2013-2020 ($million)
  • TABLE 52 Comparative Analysis biotransducers used in biosensors
  • TABLE 53 Global biosensors Market, by technology, 2013-2020 ($Billion)
  • TABLE 54 Commercial self-monitoring blood glucose systems based on electrochemical biosensors
  • TABLE 55 Optical biosensors Market, by technology, 2013-2020 ($Billion)
  • TABLE 56 Global biosensors Market, by Product, 2013-2020 ($Billion)
  • TABLE 57 Wearable biosensors Market, by product, 2013-2020 ($Billion)
  • TABLE 58 Wearable biosensors Market, by Application, 2013-2020 ($Billion)
  • TABLE 59 wrist-wear Wearable biosensors Market, by Application, 2013-2020 ($Billion)
  • TABLE 60 Non-Wearable biosensors Market, by Application, 2013-2020 ($Billion)
  • TABLE 61 Biosensors Market, By Region, 2013-2020 ($Billion)
  • TABLE 62 north America: Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 63 north America: Biosensor Market, by Application, 2013-2020 ($million)
  • TABLE 64 Europe: Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 65 Europe: Biosensor Market, by Application, 2013-2020 ($million)
  • TABLE 66 APAC: Biosensors Market, By Country, 2013-2020 ($million)
  • TABLE 67 APAC: Biosensor Market, by Application, 2013-2020 ($million)
  • TABLE 68 ROW: Biosensor Market, by Application, 2013-2020 ($million)
  • TABLE 69 new product launches, 2011-2014
  • TABLE 70 acquisitions, 2012-2014
  • TABLE 71 Partnerships and agreements, 2011-2014
  • TABLE 72 expansions, 2011-2014
  • TABLE 73 awards and recognitions, 2011-2014

LIST OF FIGURES

  • FIGURE 1 markets covered
  • FIGURE 2 RESEARCH design
  • FIGURE 3 healthcare expenditure across various prominent countries in the biosensors market, 2011
  • FIGURE 4 decentralization across various prominent countries in the biosensors market, 2011
  • FIGURE 5 prevalence of type 1 diabetes, by Age group, 2013
  • FIGURE 6 Increase in the aging population, by country (2005 vs. 2010)
  • FIGURE 7 Global Transducers market analysis and estimation : geographic split (2013 vs 2015)
  • FIGURE 8 bottom-up approach
  • FIGURE 9 top-down approach
  • FIGURE 10 market breakdown & data triangulation
  • FIGURE 11 assumptions of the research study
  • FIGURE 12 limitations of the research study
  • FIGURE 13 roadmap for biosensors
  • FIGURE 14 POC holds the prominent share among all the biosensors applications
  • FIGURE 15 North America holds the lions share in the global biosensors market
  • FIGURE 16 rising demand for POC diagnostics DEVICES likely to contribute to the GROWTH OF biosensors market
  • FIGURE 17 Point of care: largest market for biosensors, driven by the glucose monitoring application
  • FIGURE 18 Japan CAPTUREd THE maximum SHARE IN THE biosensors market in APAC, 2013
  • FIGURE 19 U.S. commanded the maximum share of the biosensors market , 2013
  • FIGURE 20 north america expected to witness the highest usage of biosensor technology, (2013)
  • FIGURE 21 Developing markets to grow faster than the developed ones
  • FIGURE 22 wearable biosensors: key growth driver for the point- of- care market
  • FIGURE 23 Road map for the biosensors technology
  • FIGURE 24 biosensors MARKET segmentation: BY application
  • FIGURE 25 biosensors MARKET segmentation: BY technology
  • FIGURE 26 biosensors market segmentation: by product
  • FIGURE 27 biosensors MARKET segmentation: BY geography
  • FIGURE 28 the growing demand for glucose monitoring in diabetic patients will propel the demand for biosensors
  • FIGURE 29 The biomedical applications of the nanobiosensors
  • FIGURE 30 VALUE CHAIN ANALYSIS (2013): MAJOR VALUE IS ADDED DURING the R&D and testing PHASEs
  • FIGURE 31 MINIATURIZATION IS THE LEADING TREND IN THE CURRENT BIOSENSORS MARKET
  • FIGURE 32 biosensor platform and business model
  • FIGURE 33 porter's five forces analysis
  • FIGURE 34 STRATEGIC BENCHMARKING: ROCHE AND BD DIAGNOSTICS LARGELY ADOPTED the INORGANIC GROWTH STRATEGIES FOR TECHNOLOGY INTEGRATION AND PRODUCT ENHANCEMENT
  • FIGURE 35 STRATEGIC BENCHMARKING: ROCHE leads the TUMOR/CANCER TESTING MARKET
  • FIGURE 36 point-of-care diagnostics
  • FIGURE 37 POC application to witness the highest growth IN APAC
  • FIGURE 38 Wearable biosensors to register a prominent growth in the POC application
  • FIGURE 39 north america holds a prominent share in the glucose monitoring biosensors market
  • FIGURE 40 europe to be one of the important markets for the coagulation monitoring biosensors
  • FIGURE 41 North america holds the largest share for the cancer markers
  • FIGURE 42 increase in the obesity diseases will drive the demand for the cholesterol testing kits
  • FIGURE 43 north america holds the largest share for the home diagnostic application
  • FIGURE 44 wearable biosensors hold a great demand in the home diagnostics applicationS
  • FIGURE 45 research lab applications to witness a prominent growth in apac
  • FIGURE 46 wearable biosensors hold the major share in the research lab applications
  • FIGURE 47 biodefense application to register a significant growth in APAC
  • FIGURE 48 Wearable biosensors are expected to witness a prominent growth in the biodefense application
  • FIGURE 49 environment monitoring application to witness a prominent growth in ROW
  • FIGURE 50 wearable biosensors dominate the environmental monitoring application segment
  • FIGURE 51 apac to witness a prominent growth for the biosensors market in the food industry
  • FIGURE 52 Types of electrochemical biosensors
  • FIGURE 53 wearable biosensors hold the major share in the biosensors market
  • FIGURE 54 APAC to grow at highest cagr for global biosensors market
  • FIGURE 55 APAC- an attractive destination for all biosensor applications
  • FIGURE 56 north america market snapshot
  • FIGURE 57 Europe: Biosensors Market, By country, 2013-2020 ($ Million)
  • FIGURE 58 APAC Market snapshot
  • FIGURE 59 china to witness prominent growth in apac
  • FIGURE 60 companies adopted new product launches as the key growth strategy over the last three years
  • FIGURE 61 abbott: GREW AT THE highest cagr BETWEEN 2009 and 2013
  • FIGURE 62 global Biosensors Market share, by key player, 2013
  • FIGURE 63 MARKET EVOLUTION FRAMEWORK
  • FIGURE 64 competition for market share: Acquisition was the key strategy
  • FIGURE 65 geographic revenue mix
  • FIGURE 66 abbott laboratories, inc.: COMPANY SNAPSHOT
  • FIGURE 67 abott point-of-care, inc.: swot analysis
  • FIGURE 68 bayer ag: COMPANY SNAPSHOT
  • FIGURE 69 f. hoffman la-roche ltd.: COMPANY SNAPSHOT
  • FIGURE 70 F. Hoffmann-La Roche Ltd.: SWOT
  • FIGURE 71 johnson & johnson: cOMPANY SNAPSHOT
  • FIGURE 72 medtronic, inc.: COMPANY SNAPSHOT
  • FIGURE 73 medtronic, inc.: swot
  • FIGURE 74 Siemens AG: COMPANY SNAPSHOT
  • FIGURE 75 siemens ag: swot
  • FIGURE 76 UNIVERSAL BIOSENSORS: COMPANY SNAPSHOT
  • FIGURE 77 universal biosensors: swot
Back to Top